92 related articles for article (PubMed ID: 11707970)
1. [Evaluation of chemosensitivity testing by CD-DST, and TS and DPD activity in cases of colorectal liver].
Tono T; Takahashi H; Kanoh T; Nakano Y; Tamagaki S; Yasue A; Okada K; Matsui S; Iwazawa T; Yano H; Kinuta M; Okamura J; Monden T
Gan To Kagaku Ryoho; 2001 Oct; 28(11):1523-6. PubMed ID: 11707970
[TBL] [Abstract][Full Text] [Related]
2. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Kihara A; Okano M
Gan To Kagaku Ryoho; 2001 May; 28(5):661-7. PubMed ID: 11383215
[TBL] [Abstract][Full Text] [Related]
3. [Thymidylate synthase and dihydropyrimidine dehydrogenase activity in a metastatic liver tumor from colorectal cancer].
Umekita N; Tanaka S; Abe H; Kitamura M
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1883-5. PubMed ID: 11086436
[TBL] [Abstract][Full Text] [Related]
4. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Horiba K; Kanazawa Y; Shirakawa T; Ohkawa K; Kudoh H; Koizumi M; Yoshioka M; Shinji S; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1603-9. PubMed ID: 17108726
[TBL] [Abstract][Full Text] [Related]
5. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
Ishida H; Yamada H; Shirakawa K; Nakada H; Ohsawa T; Takeuchi I; Okada N; Yokoyama M; Inokuma S; Suzuki T; Odaka A; Hoshino T; Murata N; Hashimoto D; Itoyama S; Mori T; Matsumoto Y; Miura T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1621-6. PubMed ID: 14619479
[TBL] [Abstract][Full Text] [Related]
6. [Activities of thymidylate synthase and dihydropyrimidine dehydrogenase in patients with colorectal cancer].
Uehara M; Takahashi S; Takenaka A; Izumi H; Fujii K; Ikawa O; Miyata K; Iizuka R; Matsumura H; Kakihara N; Shono Y; Tsuchihashi H; Saisaka Y
Gan To Kagaku Ryoho; 2001 Dec; 28(13):2035-41. PubMed ID: 11791381
[TBL] [Abstract][Full Text] [Related]
7. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
[TBL] [Abstract][Full Text] [Related]
8. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer.
Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T
Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674
[TBL] [Abstract][Full Text] [Related]
9. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C
Oncology; 2006; 70(5):366-77. PubMed ID: 17179731
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between clinical pathophysiologic factors and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
Ochiai T; Sugitani M; Nishimura K; Noguchi H; Watanabe T; Sengoku H; Komiyama H; Okano M
Gan To Kagaku Ryoho; 2002 Mar; 29(3):413-20. PubMed ID: 11915731
[TBL] [Abstract][Full Text] [Related]
11. [Dihydropyrimidine dehydrogenase gene expression in patients with hepatic metastases from colorectal cancer].
Shirota Y; Ichikawa W; Yamada H; Uetake H; Nihei Z; Sugihara K
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1729-31. PubMed ID: 10560382
[TBL] [Abstract][Full Text] [Related]
12. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
Baba H; Teramoto K; Kawamura T; Mori A; Imamura M; Arii S
Cancer Chemother Pharmacol; 2003 Dec; 52(6):469-76. PubMed ID: 13680162
[TBL] [Abstract][Full Text] [Related]
13. Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer.
Ichikawa W; Uetake H; Shirota Y; Yamada H; Nishi N; Nihei Z; Sugihara K; Hirayama R
Clin Cancer Res; 2003 Feb; 9(2):786-91. PubMed ID: 12576451
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of TS and DPD activities in colorectal carcinoma as a predictive factor of UFT sensitivity].
Funahashi K; Koike J; Saito N; Miki T; Matsumoto H; Ryu M; Shiokawa H; Tokuyama T; Goto T; Teramoto T
Gan To Kagaku Ryoho; 2004 Feb; 31(2):189-93. PubMed ID: 14997749
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between the anti-metastatic effect of UFT and in vitro chemosensitivity to 5-FU in metastatic tumors from orthotopic implanted colon cancer in nude rats].
Ogata Y; Akagi Y; Nozoe Y; Sasatomi T; Miyagi Y; Nakagawa M; Matono K; Kobayashi H; Shirouzu K
Gan To Kagaku Ryoho; 2001 May; 28(5):655-60. PubMed ID: 11383214
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between clinical pathologic factors and enzymatic activity of orotate Phosphoribosyl transferase (OPRT), Dihydropyrimidine dehydrogenase (DPD) and Thymidylate synthase (TS) in colorectal cancer].
Yamada T; Tanaka N; Yokoi K; Ishikawa N; Seya T; Kanazawa Y; Shirakawa T; Ohkawa K; Koizumi M; Ohaki Y; Yamashita K; Tajiri T
Gan To Kagaku Ryoho; 2006 Jun; 33(6):789-93. PubMed ID: 16770098
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of a combination of thymidylate synthase and dihydropyrimidine dehydrogenase activities in grades 1 and 2 superficial bladder cancer.
Mizutani Y; Wada H; Yoshida O; Fukushima M; Bonavida B; Kawauchi A; Miki T
Oncol Rep; 2002; 9(2):289-92. PubMed ID: 11836594
[TBL] [Abstract][Full Text] [Related]
18. [Immunohistologic evaluation of TS, DPD, and p53 protein expression in patients with colorectal cancer having liver and pulmonary metastases].
Ishida H; Sadahiro S; Tajima T; Makuuchi H
Nihon Rinsho; 2003 Sep; 61 Suppl 7():233-6. PubMed ID: 14574888
[No Abstract] [Full Text] [Related]
19. Expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53 and p21 in metastatic liver tumor from colorectal cancer after 5-fluorouracil-based chemotherapy.
Yamagishi S; Shimada H; Ishikawa T; Fujii S; Tanaka K; Masui H; Yamaguchi S; Ichikawa Y; Togo S; Ike H
Anticancer Res; 2005; 25(2B):1237-42. PubMed ID: 15865071
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of determinations of dihydropyrimidine dehydrogenase levels in primary and hepatic lesions of colorectal cancer patients].
Ishida H; Hashimoto D; Inokuma S; Takeuchi I; Nakada H; Ohsawa T; Hoshino T; Murata N; Fujioka M; Idezuki Y
Gan To Kagaku Ryoho; 2000 Oct; 27(12):1879-82. PubMed ID: 11086435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
